Pre-order Enquiry
Request Free Sample
Global Prescription Dermatological Drugs Market Outlook 2022
SKU ID : QYR-19588898 | Publishing Date : 24-Nov-2021 | No. of pages : 116
Detailed TOC of Global Prescription Dermatological Drugs Market Outlook 2022
1 Prescription Dermatological Drugs Market Overview1.1 Product Overview and Scope of Prescription Dermatological Drugs
1.2 Prescription Dermatological Drugs Segment by Type
1.2.1 Global Prescription Dermatological Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Anti-acne Drugs
1.2.3 Anti-aging Drugs
1.2.4 Dermatitis Drugs
1.2.5 Hair Loss Drugs
1.2.6 Psoriasis Drugs
1.2.7 Skin Cancer Drugs
1.2.8 Melasma Drugs
1.2.9 Seborrhea Drugs
1.3 Prescription Dermatological Drugs Segment by Application
1.3.1 Global Prescription Dermatological Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Prescription Dermatological Drugs Market Size Estimates and Forecasts
1.4.1 Global Prescription Dermatological Drugs Revenue 2016-2027
1.4.2 Global Prescription Dermatological Drugs Sales 2016-2027
1.4.3 Prescription Dermatological Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Prescription Dermatological Drugs Market Competition by Manufacturers
2.1 Global Prescription Dermatological Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Prescription Dermatological Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Prescription Dermatological Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Prescription Dermatological Drugs Manufacturing Sites, Area Served, Product Type
2.5 Prescription Dermatological Drugs Market Competitive Situation and Trends
2.5.1 Prescription Dermatological Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prescription Dermatological Drugs Players Market Share by Revenue
2.5.3 Global Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prescription Dermatological Drugs Retrospective Market Scenario by Region
3.1 Global Prescription Dermatological Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Prescription Dermatological Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Prescription Dermatological Drugs Market Facts & Figures by Country
3.3.1 North America Prescription Dermatological Drugs Sales by Country
3.3.2 North America Prescription Dermatological Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prescription Dermatological Drugs Market Facts & Figures by Country
3.4.1 Europe Prescription Dermatological Drugs Sales by Country
3.4.2 Europe Prescription Dermatological Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prescription Dermatological Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Prescription Dermatological Drugs Sales by Region
3.5.2 Asia Pacific Prescription Dermatological Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Prescription Dermatological Drugs Market Facts & Figures by Country
3.6.1 Latin America Prescription Dermatological Drugs Sales by Country
3.6.2 Latin America Prescription Dermatological Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prescription Dermatological Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Prescription Dermatological Drugs Sales by Country
3.7.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Prescription Dermatological Drugs Historic Market Analysis by Type
4.1 Global Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
4.2 Global Prescription Dermatological Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Prescription Dermatological Drugs Price by Type (2016-2021)
5 Global Prescription Dermatological Drugs Historic Market Analysis by Application
5.1 Global Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
5.2 Global Prescription Dermatological Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Prescription Dermatological Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Johnson & Johnson Prescription Dermatological Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Prescription Dermatological Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 LEO Pharma
6.3.1 LEO Pharma Corporation Information
6.3.2 LEO Pharma Description and Business Overview
6.3.3 LEO Pharma Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 LEO Pharma Prescription Dermatological Drugs Product Portfolio
6.3.5 LEO Pharma Recent Developments/Updates
6.4 Mylan Pharmaceuticals
6.4.1 Mylan Pharmaceuticals Corporation Information
6.4.2 Mylan Pharmaceuticals Description and Business Overview
6.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Product Portfolio
6.4.5 Mylan Pharmaceuticals Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Prescription Dermatological Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Roche Prescription Dermatological Drugs Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Allergan Prescription Dermatological Drugs Product Portfolio
6.7.5 Allergan Recent Developments/Updates
6.8 Bausch Health
6.8.1 Bausch Health Corporation Information
6.8.2 Bausch Health Description and Business Overview
6.8.3 Bausch Health Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bausch Health Prescription Dermatological Drugs Product Portfolio
6.8.5 Bausch Health Recent Developments/Updates
6.9 PharmaDerm Pharmaceuticals
6.9.1 PharmaDerm Pharmaceuticals Corporation Information
6.9.2 PharmaDerm Pharmaceuticals Description and Business Overview
6.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Portfolio
6.9.5 PharmaDerm Pharmaceuticals Recent Developments/Updates
6.10 Allergan Inamed Corporation
6.10.1 Allergan Inamed Corporation Corporation Information
6.10.2 Allergan Inamed Corporation Description and Business Overview
6.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Product Portfolio
6.10.5 Allergan Inamed Corporation Recent Developments/Updates
7 Prescription Dermatological Drugs Manufacturing Cost Analysis
7.1 Prescription Dermatological Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prescription Dermatological Drugs
7.4 Prescription Dermatological Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prescription Dermatological Drugs Distributors List
8.3 Prescription Dermatological Drugs Customers
9 Prescription Dermatological Drugs Market Dynamics
9.1 Prescription Dermatological Drugs Industry Trends
9.2 Prescription Dermatological Drugs Growth Drivers
9.3 Prescription Dermatological Drugs Market Challenges
9.4 Prescription Dermatological Drugs Market Restraints
10 Global Market Forecast
10.1 Prescription Dermatological Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prescription Dermatological Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Prescription Dermatological Drugs by Type (2022-2027)
10.2 Prescription Dermatological Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prescription Dermatological Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Prescription Dermatological Drugs by Application (2022-2027)
10.3 Prescription Dermatological Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prescription Dermatological Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Prescription Dermatological Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Prescription Dermatological Drugs Market Outlook 2022
List of TablesTable 1. Global Prescription Dermatological Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Prescription Dermatological Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Prescription Dermatological Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Prescription Dermatological Drugs Covered in This Study
Table 5. Global Prescription Dermatological Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Prescription Dermatological Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Prescription Dermatological Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Prescription Dermatological Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Prescription Dermatological Drugs Average Price (USD/Units) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Prescription Dermatological Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Prescription Dermatological Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prescription Dermatological Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Dermatological Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Prescription Dermatological Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Prescription Dermatological Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Prescription Dermatological Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Prescription Dermatological Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Prescription Dermatological Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Prescription Dermatological Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Prescription Dermatological Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Prescription Dermatological Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Prescription Dermatological Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Prescription Dermatological Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Prescription Dermatological Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Prescription Dermatological Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Prescription Dermatological Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Prescription Dermatological Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Prescription Dermatological Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Prescription Dermatological Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Prescription Dermatological Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Prescription Dermatological Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Prescription Dermatological Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Prescription Dermatological Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Prescription Dermatological Drugs Revenue Share by Type (2016-2021)
Table 42. Global Prescription Dermatological Drugs Price (USD/Units) by Type (2016-2021)
Table 43. Global Prescription Dermatological Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Prescription Dermatological Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Prescription Dermatological Drugs Revenue Share by Application (2016-2021)
Table 47. Global Prescription Dermatological Drugs Price (USD/Units) by Application (2016-2021)
Table 48. Johnson & Johnson Corporation Information
Table 49. Johnson & Johnson Description and Business Overview
Table 50. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021)
Table 51. Johnson & Johnson Prescription Dermatological Drugs Product
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021)
Table 56. Merck Prescription Dermatological Drugs Product
Table 57. Merck Recent Developments/Updates
Table 58. LEO Pharma Corporation Information
Table 59. LEO Pharma Description and Business Overview
Table 60. LEO Pharma Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021)
Table 61. LEO Pharma Prescription Dermatological Drugs Product
Table 62. LEO Pharma Recent Developments/Updates
Table 63. Mylan Pharmaceuticals Corporation Information
Table 64. Mylan Pharmaceuticals Description and Business Overview
Table 65. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021)
Table 66. Mylan Pharmaceuticals Prescription Dermatological Drugs Product
Table 67. Mylan Pharmaceuticals Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021)
Table 71. Pfizer Prescription Dermatological Drugs Product
Table 72. Pfizer Recent Developments/Updates
Table 73. Roche Corporation Information
Table 74. Roche Description and Business Overview
Table 75. Roche Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021)
Table 76. Roche Prescription Dermatological Drugs Product
Table 77. Roche Recent Developments/Updates
Table 78. Allergan Corporation Information
Table 79. Allergan Description and Business Overview
Table 80. Allergan Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021)
Table 81. Allergan Prescription Dermatological Drugs Product
Table 82. Allergan Recent Developments/Updates
Table 83. Bausch Health Corporation Information
Table 84. Bausch Health Description and Business Overview
Table 85. Bausch Health Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021)
Table 86. Bausch Health Prescription Dermatological Drugs Product
Table 87. Bausch Health Recent Developments/Updates
Table 88. PharmaDerm Pharmaceuticals Corporation Information
Table 89. PharmaDerm Pharmaceuticals Description and Business Overview
Table 90. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021)
Table 91. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product
Table 92. PharmaDerm Pharmaceuticals Recent Developments/Updates
Table 93. Allergan Inamed Corporation Corporation Information
Table 94. Allergan Inamed Corporation Description and Business Overview
Table 95. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (K Units), Revenue (Million US$), Price (USD/Units) and Gross Margin (2016-2021)
Table 96. Allergan Inamed Corporation Prescription Dermatological Drugs Product
Table 97. Allergan Inamed Corporation Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Prescription Dermatological Drugs Distributors List
Table 101. Prescription Dermatological Drugs Customers List
Table 102. Prescription Dermatological Drugs Market Trends
Table 103. Prescription Dermatological Drugs Growth Drivers
Table 104. Prescription Dermatological Drugs Market Challenges
Table 105. Prescription Dermatological Drugs Market Restraints
Table 106. Global Prescription Dermatological Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 107. Global Prescription Dermatological Drugs Sales Market Share Forecast by Type (2022-2027)
Table 108. Global Prescription Dermatological Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 109. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 110. Global Prescription Dermatological Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 111. Global Prescription Dermatological Drugs Sales Market Share Forecast by Application (2022-2027)
Table 112. Global Prescription Dermatological Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 113. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 114. Global Prescription Dermatological Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 115. Global Prescription Dermatological Drugs Sales Market Share Forecast by Region (2022-2027)
Table 116. Global Prescription Dermatological Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 117. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prescription Dermatological Drugs
Figure 2. Global Prescription Dermatological Drugs Market Share by Type in 2020 & 2027
Figure 3. Anti-acne Drugs Product Picture
Figure 4. Anti-aging Drugs Product Picture
Figure 5. Dermatitis Drugs Product Picture
Figure 6. Hair Loss Drugs Product Picture
Figure 7. Psoriasis Drugs Product Picture
Figure 8. Skin Cancer Drugs Product Picture
Figure 9. Melasma Drugs Product Picture
Figure 10. Seborrhea Drugs Product Picture
Figure 11. Global Prescription Dermatological Drugs Market Share by Application in 2020 & 2027
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Global Prescription Dermatological Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Prescription Dermatological Drugs Market Size 2016-2027 (US$ Million)
Figure 17. Global Prescription Dermatological Drugs Sales 2016-2027 (K Units)
Figure 18. Global Prescription Dermatological Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 19. Prescription Dermatological Drugs Sales Share by Manufacturers in 2020
Figure 20. Global Prescription Dermatological Drugs Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest Prescription Dermatological Drugs Players: Market Share by Revenue in 2020
Figure 22. Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global Prescription Dermatological Drugs Sales Market Share by Region (2016-2021)
Figure 24. Global Prescription Dermatological Drugs Sales Market Share by Region in 2020
Figure 25. Global Prescription Dermatological Drugs Revenue Market Share by Region (2016-2021)
Figure 26. Global Prescription Dermatological Drugs Revenue Market Share by Region in 2020
Figure 27. U.S. Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Taiwan Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Philippines Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Vietnam Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Mexico Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Brazil Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Argentina Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. U.A.E Prescription Dermatological Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of Prescription Dermatological Drugs by Type (2016-2021)
Figure 52. Sales Market Share of Prescription Dermatological Drugs by Application (2016-2021)
Figure 53. Sales Market Share of Prescription Dermatological Drugs by Application in 2020
Figure 54. Revenue Share of Prescription Dermatological Drugs by Application (2016-2021)
Figure 55. Revenue Share of Prescription Dermatological Drugs by Application in 2020
Figure 56. Manufacturing Cost Structure of Prescription Dermatological Drugs
Figure 57. Manufacturing Process Analysis of Prescription Dermatological Drugs
Figure 58. Prescription Dermatological Drugs Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Keyplayers in Global Prescription Dermatological Drugs Market Outlook 2022
Johnson & JohnsonMerck
LEO Pharma
Mylan Pharmaceuticals
Pfizer
Roche
Allergan
Bausch Health
PharmaDerm Pharmaceuticals
Allergan Inamed Corporation
Request Sample
Request Discount
